1. Home
  2. WAT vs AFRM Comparison

WAT vs AFRM Comparison

Compare WAT & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • AFRM
  • Stock Information
  • Founded
  • WAT 1958
  • AFRM 2012
  • Country
  • WAT United States
  • AFRM United States
  • Employees
  • WAT N/A
  • AFRM N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • AFRM Business Services
  • Sector
  • WAT Industrials
  • AFRM Consumer Discretionary
  • Exchange
  • WAT Nasdaq
  • AFRM Nasdaq
  • Market Cap
  • WAT 17.8B
  • AFRM 21.3B
  • IPO Year
  • WAT 1995
  • AFRM 2021
  • Fundamental
  • Price
  • WAT $309.50
  • AFRM $85.88
  • Analyst Decision
  • WAT Hold
  • AFRM Buy
  • Analyst Count
  • WAT 14
  • AFRM 26
  • Target Price
  • WAT $374.07
  • AFRM $79.86
  • AVG Volume (30 Days)
  • WAT 563.4K
  • AFRM 9.6M
  • Earning Date
  • WAT 10-31-2025
  • AFRM 11-06-2025
  • Dividend Yield
  • WAT N/A
  • AFRM N/A
  • EPS Growth
  • WAT 10.77
  • AFRM N/A
  • EPS
  • WAT 11.09
  • AFRM 0.15
  • Revenue
  • WAT $3,046,056,000.00
  • AFRM $3,224,412,000.00
  • Revenue This Year
  • WAT $7.19
  • AFRM $22.56
  • Revenue Next Year
  • WAT $6.40
  • AFRM $22.65
  • P/E Ratio
  • WAT $27.91
  • AFRM $561.21
  • Revenue Growth
  • WAT 5.89
  • AFRM 38.80
  • 52 Week Low
  • WAT $275.05
  • AFRM $30.90
  • 52 Week High
  • WAT $423.56
  • AFRM $100.00
  • Technical
  • Relative Strength Index (RSI)
  • WAT 58.10
  • AFRM 60.44
  • Support Level
  • WAT $286.14
  • AFRM $81.60
  • Resistance Level
  • WAT $302.94
  • AFRM $93.20
  • Average True Range (ATR)
  • WAT 8.17
  • AFRM 4.64
  • MACD
  • WAT 2.35
  • AFRM 0.62
  • Stochastic Oscillator
  • WAT 97.05
  • AFRM 51.74

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About AFRM Affirm Holdings Inc.

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

Share on Social Networks: